6-(2-(1-(6-chloropyridazin-3-yl)piperidin-4-yl)ethoxy)-3-ethoxybenzo[d]isoxazole

ID: ALA2062776

PubChem CID: 504459

Max Phase: Preclinical

Molecular Formula: C20H23ClN4O3

Molecular Weight: 402.88

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1noc2cc(OCCC3CCN(c4ccc(Cl)nn4)CC3)ccc12

Standard InChI:  InChI=1S/C20H23ClN4O3/c1-2-26-20-16-4-3-15(13-17(16)28-24-20)27-12-9-14-7-10-25(11-8-14)19-6-5-18(21)22-23-19/h3-6,13-14H,2,7-12H2,1H3

Standard InChI Key:  OYNNBELKYCYRRG-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   15.3292    0.9025    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1526    0.9013    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5614    1.6132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1521    2.3267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3256    2.3239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9163    1.6114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0913    1.6090    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   17.3865    1.6130    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7992    0.8955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6207    0.8934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0353    1.6067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6262    2.3236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7985    2.3275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8604    1.6034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2779    2.3168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1030    2.3135    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.5106    1.5967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0970    0.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5041    0.1702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3339    1.5983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7474    0.8850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3303    0.1684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8844   -0.4445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6414   -0.1109    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.5566    0.7123    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.7123   -1.2514    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.9270   -1.5079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7549   -2.3148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
 11 14  1  0
  6  7  1  0
 14 15  1  0
  3  4  2  0
 15 16  1  0
  3  8  1  0
 16 17  1  0
  8  9  1  0
 17 18  2  0
 18 19  1  0
 19 22  2  0
  4  5  1  0
 21 20  2  0
 20 17  1  0
 21 22  1  0
  2  3  1  0
  5  6  2  0
  6  1  1  0
  8 13  1  0
  9 10  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  1  0
 10 11  1  0
 23 26  1  0
 11 12  1  0
 26 27  1  0
 12 13  1  0
 27 28  1  0
M  END

Associated Targets(non-human)

rhinovirus A2 (409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human rhinovirus sp. (1587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 402.88Molecular Weight (Monoisotopic): 402.1459AlogP: 4.36#Rotatable Bonds: 7
Polar Surface Area: 73.51Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.14CX LogP: 3.96CX LogD: 3.96
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.64

References

1. Feil SC, Hamilton S, Krippner GY, Lin B, Luttick A, McConnell DB, Nearn R, Parker MW, Ryan J, Stanislawski PC, Tucker SP, Watson KG, Morton CJ..  (2012)  An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human Rhinovirus.,  (4): [PMID:24900468] [10.1021/ml2002955]

Source